Short-term healing response after implantation of the thin-strut, fast-releasing sirolimus-eluting biodegradable polymer-coated Alex Plus stent: optical coherence tomography study
- PMID: 32636904
- PMCID: PMC7333208
- DOI: 10.5114/aic.2020.96062
Short-term healing response after implantation of the thin-strut, fast-releasing sirolimus-eluting biodegradable polymer-coated Alex Plus stent: optical coherence tomography study
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
-
Very thin strut biodegradable polymer everolimus-eluting and sirolimus-eluting stents versus durable polymer zotarolimus-eluting stents in allcomers with coronary artery disease (BIO-RESORT): a three-arm, randomised, non-inferiority trial.Lancet. 2016 Nov 26;388(10060):2607-2617. doi: 10.1016/S0140-6736(16)31920-1. Epub 2016 Oct 30. Lancet. 2016. PMID: 27806902 Clinical Trial.
-
Three-months optical coherence tomography analysis of a biodegradable polymer, sirolimus-eluting stent.J Interv Cardiol. 2018 Aug;31(4):442-449. doi: 10.1111/joic.12510. Epub 2018 Apr 12. J Interv Cardiol. 2018. PMID: 29651802
-
Bioresorbable polymer-coated thin strut sirolimus-eluting stent vs durable polymer-coated everolimus-eluting stent in daily clinical practice: Propensity matched one-year results from interventional cardiology network registry.Catheter Cardiovasc Interv. 2019 Jun 1;93(7):E362-E368. doi: 10.1002/ccd.27919. Epub 2018 Oct 8. Catheter Cardiovasc Interv. 2019. PMID: 30298545
-
Safety and efficacy of ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer drug-eluting stents: a meta-analysis of randomized trials.BMC Cardiovasc Disord. 2018 Aug 15;18(1):170. doi: 10.1186/s12872-018-0902-5. BMC Cardiovasc Disord. 2018. PMID: 30111289 Free PMC article. Review.
-
Evaluation of the MiStent sustained sirolimus eluting biodegradable polymer coated stent for the treatment of coronary artery disease: does uniform sustained abluminal drug release result in earlier strut coverage and better safety profile?Expert Rev Med Devices. 2017 May;14(5):325-334. doi: 10.1080/17434440.2017.1318057. Epub 2017 Apr 24. Expert Rev Med Devices. 2017. PMID: 28402204 Review.
Cited by
-
Clinical Outcomes and Prognostic Factors in Complex, High-Risk Indicated Procedure (CHIP) and High-Bleeding-Risk (HBR) Patients Undergoing Percutaneous Coronary Intervention with Sirolimus-Eluting Stent Implantation: 4-Year Results.J Clin Med. 2023 Aug 15;12(16):5313. doi: 10.3390/jcm12165313. J Clin Med. 2023. PMID: 37629356 Free PMC article.
-
48-Month Clinical Outcomes and Prognostic Factors in an All-Comers Population with Acute Coronary Syndrome and Chronic Coronary Syndrome Undergoing Percutaneous Coronary Intervention with a Sirolimus-Eluting Stent.J Pers Med. 2023 Nov 3;13(11):1573. doi: 10.3390/jpm13111573. J Pers Med. 2023. PMID: 38003888 Free PMC article.
-
Percutaneous Coronary Interventions with Sirolimus-Eluting Alex Plus Stents in Patients with or without Diabetes: 4-Year Results.J Cardiovasc Dev Dis. 2024 May 22;11(6):160. doi: 10.3390/jcdd11060160. J Cardiovasc Dev Dis. 2024. PMID: 38921660 Free PMC article.
-
Assessment of Effectiveness of the Algorithm for Automated Quantitative Analysis of Metallic Strut Tissue Short-Term Coverage with Intravascular Optical Coherence Tomography.J Clin Med. 2024 Jul 25;13(15):4336. doi: 10.3390/jcm13154336. J Clin Med. 2024. PMID: 39124606 Free PMC article.
-
Thin-strut bioresorbable-polymer sirolimus-eluting stent use for an optimal result of rescue coronary angioplasty in acute myocardial infarction failed thrombolytic therapy: the Bangladesh National Heart Foundation Annual Conference OCT-assisted live case.Postepy Kardiol Interwencyjnej. 2021 Sep;17(3):309-312. doi: 10.5114/aic.2021.109834. Epub 2021 Oct 20. Postepy Kardiol Interwencyjnej. 2021. PMID: 34819968 Free PMC article. No abstract available.
References
-
- Orlik B, Buszman PP, Krauze A, et al. A nuclear magnetic resonance spectroscopy as a method for evaluation of in vivo poly-l-lactide biodegradation kinetics from stent-polymer matrices: an experimental study utilizing porcine model of in-stent restenosis. J Cardiovasc Pharmacol Ther. 2016;21:93–6. - PubMed
-
- Vesga B, Hernandez H, Moncada M, et al. Three-month evaluation of strut healing using a novel optical coherence tomography analytical method following bioresorbable polymer everolimus-eluting stent implantation in humans: the TIMELESS study. Coron Artery Dis. 2017;28:126–34. - PubMed
-
- Stettler C, Wandel S, Allemann S, et al. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet. 2007;370:937–48. - PubMed
-
- Lupi A, Gabrio Secco G, Rognoni A, et al. Meta-analysis of bioabsorbable versus durable polymer drug-eluting stents in 20,005 patients with coronary artery disease: an update. Catheter Cardiovasc Interv. 2014;83:E193–206. - PubMed
-
- Finn AV, Joner M, Nakazawa G, et al. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation. 2007;115:2435–41. - PubMed
LinkOut - more resources
Full Text Sources